🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Mesenteric Infiltration in Ovarian Cancer

Recruitingn/aAges 18 Years - anyFemaleFondazione Policlinico Universitario Agostino Gem…
NCT06331130 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

To evaluate if CT features at diagnosis in patients with HGSOC can be used to build an Artificial Intelligence model capable of discerning the pathological involvement of the mesentery, assessing the potential impediments for an optimal debulking surgery and predicting the development of resistance to platinum based chemotherapeutic agents.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Women with confirmed HGSOC wiht mesenteric involvment 2. Age \> 18 years 3. FIGO STAGE IIIB-IV 4. Primary diagnosis 5. Signed informed consent Exclusion Criteria: 1. Non-serous high grade epithelial ovarian cancer (serous low grade, mucinous, clear cell carcinoma, endometrioid or non-epithelial ovarian cancer) 2. Early stage disease (I and II stage) 3. CT scan not available 4. Non-primary diagnosis or patient subjected to neoadjuvant chemotherapy
💊

What it tests

  • Computed Tomography
📍

Where

1 site
Advanced Radiology Center
Roma, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy